ratios in their spectra could not be accurately determined.21 While
short of a retraction, it does raise questions concerning the utility
of 29Si NMR, a technique with intrinsically low sensitivity compared
with those of other techniques. Raman and FT-IR microscopy
have been used to identify silicone in capsular tissue and in
regional lymph nodes of women with implants.22,23,24,25 A limitation
of IR and Raman spectroscopy is that, as applied, they do not give
quantitative information.
Extraction in conjunction with gas chromatographic techniques
was used to follow migration of low molecular weight cyclics (D3
to D7) following injection in mice.26 Silicones were identified by
use of mass spectral or atomic emission detectors. Whereas these
techniques unequivocally identified various cyclics in tissue, the
injected doses of approximately 10 g/ kg of body weight would
be equivalent to injecting a human with half a kilogram of cyclics.
Since medical devices consist of polymeric silicones with only
traces of the volatile low molecular weight cyclics, the extraction
and GC techniques have limited practical utility.
A technique which can specifically detect dimethylsiloxane
oligomers and polymers is known in the silicone industry as the
Aqueous Silanol Functionality Test (ASFT).27 In this procedure,
an aqueous sample containing silicone species is digested by
acidifying to 10-15 wt % HCl and shaking for 1-7 days. During
this period, silicones are hydrolyzed to the monomeric units:
(CH3)2Si(OH)2, CH3Si(OH)3, and Si(OH)4. A small amount, typi-
cally 2 mL, of hexamethyldisiloxane (MM) is then added to the
digested sample, and the sample is shaken an additional 1-7 days.
During this time, all silanol species are capped with trimethylsilyl
groups and extracted into the hexamethyldisiloxane layer. Thus,
(CH3)2Si(OH)2, CH3Si(OH)3, and Si(OH)4 are converted to MDM,
M3T, and M4Q, respectively. The hexamethyldisiloxane layer is
then isolated and analyzed by GC versus appropriate standards.
The technique is capable of detecting sub ppm levels of (CH3)2-
SiO in aqueous samples.
The great sensitivity of the ASFT is attributed to several factors.
Capping silanols with trimethylsilyl groups eliminates the tendency
for the analytes to undergo condensation reactions in the GC. Also,
capping results in a significant mass increase, which greatly
enhances sensitivity when using a GC/ FID detector. For example,
in the case of the D unit, capping increases the mass from 74 to
236. Lastly, depending on the ratio of the original sample to the
hexamethyldisiloxane phase, significant concentration enhance-
ments are possible by extraction of the analytes of interest into a
smaller volume. Another great advantage to the technique is that,
if the hydrolysis can be run under conditions where methyl
Ta b le 1 . Re p o rt e d No rm a l S ilic o n Le ve ls in Blo o d o r
Blo o d Co m p o n e n t s
matrix mean µg of Si/ mL
technique
ref
blood
blood
blood
plasma
plasma
serum
blood
6.24
1.29
0.5a
0.17
0.14
0.13
0.0250
AA
4
5
6
7
3
8
9
digestion/ colorimetric analysis
DC-PES
GF-AAS
DC-PES
ICP-AES
GF-AAS
a
Approximate median.
weight species. Losses may also occur during sample digestion
procedures as a result of the volatility of low molecular weight
silicones or silanes that may be generated during acid digestions.
Instrumental concerns include the materials of construction of a
spectrometer which can cause problems through interaction with
silicon compounds or leaching of silicon compounds as contami-
nates.
The focus of this paper is the detection of silicones. Poly-
(dimethylsiloxane) (PDMS) is by far the most common form of
silicone produced commercially, and it is also the form of silicone
most widely used in medical applications. Therefore, any test for
detecting silicones in biological tissues should be sensitive to the
dimethylsiloxane moiety. In discussing such tests, it is convenient
to use a silicone shorthand notation that is commonly used in
the industry. In this notation, M, D, T, and Q denote (CH3)3SiO1/ 2
,
(CH3)2SiO, CH3SiO3/ 2, and SiO4/ 2 respectively. Thus, MDM, M3T,
and M4Q are short for (CH3)3SiO(CH3)2SiOSi(CH3)3, ((CH3)3-
SiO)3Si(CH3), and ((CH3)3SiO)4Si, respectively. Using this nota-
tion, the common trimethylsilyl-terminated poly(dimethylsiloxane)
would be denoted as MDnM.
Radiolabeling methyl groups of poly(dimethylsiloxane) with
14C provides a very sensitive and specific tag for detecting silicone
in tissues. Silicone labeled with 14C was used to monitor silicone
migration from gels implanted in rats.16 A technique involving
radiolabeled octamethylcyclotetrasiloxane (D4) has been devel-
oped for use in distribution and metabolism investigations.17
Obviously, the technique is only useful if the silicone source has
been labeled with an appropriate tag.
Silicone-specific spectroscopic techniques such as 29Si NMR,
FT-IR, and Raman have been used to detect silicone in biological
tissues. 29Si NMR was used to detect silicone degradation products
in the blood of women with implants.18 However, reported silicon
levels were 4-5 orders of magnitude higher than levels reported
by atomic spectroscopy techniques. As a result, the reported high
levels in blood have been challenged,19,20 and the original authors
have since published an erratum stating that the signal-to-noise
(19) Macdonald, P.; Plavac, N.; Peters, W.; Lugowski, S.; Smith, D. Anal. Chem.
1 9 9 5 , 67, 3799-3801.
(20) Taylor, R. B.; Kennan, J. J. Magn. Res. Med. 1 9 9 6 , 36, 498-501.
(21) Garrido, L.; Pfleiderer, B.; Jenkins, B. G.; Hulka, C. A.; and Kopans, D. B.
Magn. Reson. Med. 1 9 9 8 , 39, 689.
(13) Lugowski, S. J.; Smith, D. C.; Lugowski, J. Z.; Peters, W.; Semple, J. Fresenius’
J. Anal. Chem. 1 9 9 8 , 360, 486-488.
(22) Frank, C. J.; McCreery, R. L.; Redd, D. C. B.; Gansler, T. S. Appl. Spectrosc.
1 9 9 3 , 47, 387-390.
(14) Smith, A. L.; Parker, R. D. In The Analytical Chemistry of Silicones; Smith,
A. L., Ed.; Chemical Analysis 112; Wiley: New York, 1991; pp 71-95.
(15) Cavic-Vlasak, B. A.; Thompson, M.; Smith, D. C. Analyst (Cambridge, U.K.)
1 9 9 6 , 1121, 53R-63R.
(23) Hardt, N. S.; Yu, L. T.; La Torre, G.; Steinbach, B. Mod. Pathology 1 9 9 4 , 7,
669-676.
(24) Kidder, L. H.; Kalasinsky, V. F.; Luke, J. L.; Levin, I. W.; Lewis, E. N. Nat.
Med. (NY) 1 9 9 7 , 3, 235-237.
(16) Schulz, C. O.; Lee, G.; Mathews, J. M. Toxicologist, 1 9 9 3 , 13 (1), 381;
(25) Ali, S. R.; Johnson, F. B.; Luke, J. L.; Kalasinsky, V. F. Cell. Mol. Biol. 1 9 9 8 ,
44, 75-80.
Abstract 1491.
(17) Varaprath, S.; Salyers, K. L.; Plotzke, K. P.; Nanavati, S. Anal. Biochem.
1 9 9 8 , 256 (1), 14-22.
(26) Kala, S. V.; Lykissa, E. D.; Neely, M. W.; Lieberman, M. W. Am. J. Pathol.
1 9 9 8 , 152, 645-649.
(18) Garrido, L.; Pfleiderer, B.; Jenkins, B. G.; Hulka, C. A.; Kopans, D. B. Magn.
(27) Mahone, L. G.; Garner, P. J.; Buch, R. R.; Lane, T. H.; Tatera, J. F.; Smith,
R. C.; Frye, C. L. Environ. Toxicol. Chem. 1 9 8 3 , 2, 307-313.
Reson. Med. 1 9 9 4 , 31, 328-330.
Analytical Chemistry, Vol. 71, No. 15, August 1, 1999 3055